SAA1 and acute myeloid leukemia: Thus, considering the role of SAA1 in the inflammatory context, the expression of these proteins as possible serum biomarkers for many tumors [29] and their increased expression in the BM microenvironment of AML patients, we selected SAA1 to confirm its expression via ELISA.